孟魯司特鈉聯(lián)合硫酸沙丁胺醇治療小兒支氣管哮喘的效果

打開文本圖片集

【摘要】目的：探討孟魯司特鈉聯(lián)合硫酸沙丁胺醇對小兒支氣管哮喘的效果。方法：選取2021年1月—2022年6我院的70例支氣管哮喘患兒，隨機分成兩組。對照組采用硫酸沙丁胺醇，觀察組聯(lián)用孟魯司特鈉。結(jié)果：治療前，兩組的CD3+、CD4+、CD4+/CD8+和CD8+水平無明顯差異（P>0.05），治療后，兩組均明顯改善（P0.05），治療后，兩組均明顯升高（P

【關(guān)鍵詞]】孟魯司特鈉；硫酸沙丁胺醇；小兒支氣管哮喘

Effect of montelukast sodium combined with salbutamol sulfate on children with bronchial asthma

XIONG Huanhuan1， GUO Bo2

1.Maternal and Child Health and Family Planning Service Center of Lantian， Xi’an， Shaanxi 710500， China 2.Lantian County People’s Hospital， Xi’an， Shaanxi 710500， China

【Abstract】Objective：To investigate the effect of montelukast sodium combined with salbutamol sulfate on children with bronchial asthma. Methods：70 children with bronchial asthma in our hospital from January 2021 to June 2022 were randomly divided into two groups. The control group was treated with salbutamol sulfate， and the observation group was treated with montelukast sodium on the basis of control group. Results：Before treatment， there was no significant difference in the levels of CD3+， CD4+， CD4+/CD8+and CD8+between the two groups （P>0.05）. After treatment， both groups improved significantly （P0.05）. After treatment， both groups significantly increased （P

【Key Words】Montelukast sodium； Salbutamol sulfate； Children with bronchial asthma

支氣管哮喘發(fā)病是多因素引起的一個疾病過程，包括環(huán)境、個體炎癥、遺傳等等[1]。（剩余3929字）